Ironwood Pharmaceuticals reported $2.13M in Trade Creditors for its fiscal quarter ending in December of 2024.


Trade Creditors Change Date
Acadia Pharmaceuticals USD 20.1M 2M Jun/2025
Agios Pharmaceuticals USD 17.53M 3.81M Jun/2025
Almirall EUR 199.39M 50.03M Jun/2025
Alnylam Pharmaceuticals USD 102.39M 4.99M Jun/2025
Amarin USD 45.66M 5.3M Mar/2025
Ardelyx USD 21.68M 5.68M Jun/2025
Astellas Pharma JPY 165.89B 21.95B Jun/2025
AstraZeneca 23.99B 1.44B Jun/2025
Charles River Laboratories USD 145.8M 3.54M Jun/2025
Exact Sciences USD 157.32M 15.15M Jun/2025
Halozyme Therapeutics USD 18.69M 1.38M Jun/2025
Incyte USD 1.41B 1.21B Jun/2025
Ironwood Pharmaceuticals USD 2.13M 1.11M Dec/2024
MacroGenics USD 4.66M 353K Jun/2025
Moderna USD 175M 51M Jun/2025
Myriad Genetics USD 28.1M 4.2M Mar/2025
Pacira USD 30.12M 6.95M Jun/2025
PTC Therapeutics USD 206.31M 191.16M Jun/2025
Sarepta Therapeutics USD 136.7M 19.4M Jun/2025
Takeda JPY 421.31B 54.23B Jun/2025
Ultragenyx Pharmaceutical USD 34.24M 13.21M Jun/2025